MoneyWorks4Me

Phaarmasia informs about closure of trading window

30 Mar 2024 Evaluate
Phaarmasia has informed that in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, the Company has intimated to all its Directors, Key Management Personnel and Designated Employees regarding the Closure of the Trading Window of the Company from 01.04.2024 till 48 hours from the conclusion of Board meeting in which the Unaudited Financial result for the Quarter and year ended 31st March, 2024 will be approved. This closure of the Trading Window is occasioned by reason of declaration of financial results for the quarter and year ended 31 March, 2024. All the insiders (including Directors, Key Managerial Personnel and designated employees) and their immediate relatives are hereby directed to take notice that in terms of trading restrictions placed under above regulations, shares of the Company shall not be dealt in during the period of closure of Trading Window as stated above. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..